These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 17699403)
1. Therapeutic monitoring of mycophenolate mofetil. Jeong H; Kaplan B Clin J Am Soc Nephrol; 2007 Jan; 2(1):184-91. PubMed ID: 17699403 [No Abstract] [Full Text] [Related]
2. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection. Nicholls AJ Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430 [No Abstract] [Full Text] [Related]
3. Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary? Mourad M; Wallemacq P; König J; de Frahan EH; Eddour DC; De Meyer M; Malaise J; Squifflet JP Clin Pharmacokinet; 2002; 41(5):319-27. PubMed ID: 12036390 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug level monitoring for mycophenolate mofetil: is it justified? Stephan A; Masri MA; Barbari A; Kamel G; Karam A; Kilani H Transplant Proc; 2001 Aug; 33(5):2778-9. PubMed ID: 11498157 [No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil. Bell J; Ross K ANNA J; 1996 Aug; 23(4):409-10, 413. PubMed ID: 8900688 [No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes? Byrne R; Yost SE; Kaplan B Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295 [No Abstract] [Full Text] [Related]
8. [Mycophenolate mofetil in comparison with other immunosuppressive drugs]. Schnülle P; van der Woude FJ Internist (Berl); 1998 Aug; 39(8):879-86. PubMed ID: 9757398 [No Abstract] [Full Text] [Related]
9. Therapeutic drug monitoring for mycophenolic acid is value for (little) money. van Gelder T Clin Pharmacol Ther; 2011 Aug; 90(2):203-4. PubMed ID: 21772294 [No Abstract] [Full Text] [Related]
10. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. van Gelder T; Le Meur Y; Shaw LM; Oellerich M; DeNofrio D; Holt C; Holt DW; Kaplan B; Kuypers D; Meiser B; Toenshoff B; Mamelok RD Ther Drug Monit; 2006 Apr; 28(2):145-54. PubMed ID: 16628123 [TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive drug monitoring of cyclosporine, tacrolimus, and mycophenolate mofetil in renal transplantation]. Uchida K Nihon Jinzo Gakkai Shi; 2005; 47(4):423-9. PubMed ID: 15971884 [No Abstract] [Full Text] [Related]
13. [Therapeutic drug monitoring of mycophenolate mofetil, sirolimus and cyclosporine at C2]. Royer B; Davani S; Bérard M; Kantelip JP; Muret P Ann Biol Clin (Paris); 2003; 61(3):251-8. PubMed ID: 12805001 [TBL] [Abstract][Full Text] [Related]
15. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Shaw LM; Holt DW; Oellerich M; Meiser B; van Gelder T Ther Drug Monit; 2001 Aug; 23(4):305-15. PubMed ID: 11477311 [No Abstract] [Full Text] [Related]
16. Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid. Shaw LM; Korecka M; van Breeman R; Nowak I; Brayman KL Clin Biochem; 1998 Jul; 31(5):323-8. PubMed ID: 9721429 [No Abstract] [Full Text] [Related]
18. Mycophenolate mofetil for rescue therapy in acute renal transplant rejection in children should always be monitored by measurement of trough concentration. Filler G; Ehrich J Nephrol Dial Transplant; 1997 Feb; 12(2):374-5. PubMed ID: 9132677 [No Abstract] [Full Text] [Related]